Neuro-Oncology
Response Assessment in Pediatric Neuro Oncology: Implementation and Expansion of the RANO Criteria in a Randomized Phase II Trial of Pediatric Patients with Newly Diagnosed High Grade Gliomas
... Standardization is important for both conventional MR imag- ing and the diffusion/perfusion techniques being used in HERBY, these latter being, to date, largely experimental. Future trials will require a consensus on ...
7
Delays in Discharge in Neuro-Oncology: Using a Lean Six Sigma-Inspired Approach to Identify Internal Causes
... Discharge planning processes have implications for patients and families, healthcare providers, and organizations at large. As such, delays in discharge may result in suboptimal patient outcomes, increased resource ...
7
Current and Future Imaging Methods for Evaluating Response to Immunotherapy in Neuro-Oncology
... Non-invasive, longitudinal imaging is central to measuring the progression of disease and the efficacy of treatment in neuro-oncology. Historically, response criteria based on conventional imaging through ...
20
The EPTN consensus-based atlas for CT- and MR-based contouring in neuro-oncology
... The presented atlas for contouring OARs involved in neuro- oncology aims at reducing the inter- and intra-observer delin- eation variability and thus enabling more consistent plan compar- ison. This is ...
7
Social and structural conditions for the avoidance of advance care planning in neuro-oncology: a qualitative study
... in neuro-oncology, or in other countries, where both health policy and healthcare delivery may differ substantially from the care delivered in the ...
10
Response Assessment in Neuro Oncology Criteria for Gliomas: Practical Approach Using Conventional and Advanced Techniques
... in Neuro-Oncology criteria were developed as an objective tool for radiologic assessment of treatment response in high-grade ...in Neuro-Oncology cri- teria for high-grade and lower-grade ...
11
Applications of molecular neuro-oncology - a review of diffuse glioma integrated diagnosis and emerging molecular entities
... Insights into the molecular underpinnings of primary central nervous system tumors have radically changed the approach to tumor diagnosis and classification. Diagnostic emphasis has shifted from the morphology of a tumor ...
16
Neuro-oncology family caregivers’ view on keeping track of care issues using eHealth systems: it’s a question of time
... in neuro-oncology, some utilizing eHealth or telehealth solutions [30], none so far include the option to keep track of care issues over time to only pro- vide supportive care as ...
11
The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care
... DNA methylation profiling is an emerging powerful tool that can resolve diagnostic discrepancies and provide ob- jective evidence to help classify challenging CNS tumor cases [11, 12, 16, 17]. There is increasing support ...
10
Integrating psychosocial care into neuro-oncology: challenges and strategies
... in neuro-oncology in general, is represented by a frequently undetected and under-recognized possible effect of psychiatric dis- orders, mainly cognitive impairment, in reducing patients’ mental capacity ...
6
Prognostic Factors and Treatment Outcome in Glial Brain Tumors; Data from the Third Neuro-oncology Scientific Club’s Input Forum, 2013, Mashhad, Iran
... the neuro-oncology clinical investigations and ongoing brain tumor trials conducted in ...in neuro-oncology practice in our local setting and 3- role of the Cancer Research Center of Mashhad ...
16
Paediatric neuro-oncology rehabilitation in the UK: carer and provider perspectives
... CCLG’s Neuro- oncology Special Interest Group and a paedi- atric neuro- rehabilitation nurse specialist at University Hospital Southampton NHS Foundation ...‘Neuro- oncology ...
8
An investigation into the spiritual needs of neuro oncology patients from a nurse perspective
... palliative, oncology, neurology, and psychiatric settings as well as ...for neuro-oncology patients as supported by previous research ...by neuro- oncology patients ...
11
The Danish Neuro Oncology Registry: establishment, completeness and validity
... Danish Neuro-Oncology Group (DNOG) is the Dan- ish Multidisciplinary Cancer Group for adult patients with primary brain ...ish Neuro-Oncology Registry (DNOR) was established under the auspices ...
7
Radiomics in paediatric neuro oncology : MRI textural features as diagnostic and prognostic biomarkers
... Thirdly, it was shown, through the analysis of clinical medulloblastoma data, that TA can be used to predict the survival prognosis of the patients, using features extracted from convent[r] ...
241
CAR-T cell therapy in neuro-oncology: applications and toxicity
... A new era for cancer treatment has been ushered in with the field of cancer immunotherapy. After initial success with systemic malignancies, several of these promising treatments are being investigated for efficacy with ...
12
Combining random forest and 2D correlation analysis to identify serum spectral signatures for neuro-oncology
... Generalised 2D correlational analysis was then employed to further augment the machine learning, and also to establish spectral features important for the distinction between cancer and [r] ...
21
Neuro-ophthalmic sarcoidosis
... Figure 3 provides a general approach to the diagnosis of neuro-ophthalmic sarcoidosis. For patients with known sarcoidosis, the presence of one or more features listed can lead to a definite diagnosis of ...
13
Neuro Ophthalmology for Neuroradiologists
... Table 1: Localization of field defects and disorders of higher cortical visual function Field Defect or Syndrome Unilateral central scotoma Bitemporal hemianopsia Junctional defect ipsil[r] ...
6
Social problems in oncology
... in that we continued across a broad group of diagnoses and patient characteristics until no new items were identified (‘saturation’). The number of patients declining to take part in the patient study was high which was ...
6